Outcome of autologous bone marrow transplant in patients with relapsed and refractory diffuse large B-cell lymphoma in relation with prognostic factor: A single-center experience

BACKGROUND: Currently, about 50% of diffuse large B-cell lymphoma patients are relapsed following their complete response to first-line therapy. The treatment strategy for fit patients with relapsed refractory diffuse large B-cell lymphoma (R/R DLBCL) has been done with salvage therapy with non-cros...

Full description

Saved in:
Bibliographic Details
Main Authors: Fawaz Salim Yousif, Bassam Francis Matti, Zina Ali Al-Bakri, Safa A. Faraj, Mazin A. Mohammed, Zahraa S. Shakir, Mahmood W. Khalid, Saba H. Al Hlali, Sarah M. Saeb, Kareem K. Khanjar, Maryam R. Humadi
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2024-12-01
Series:Iraqi Journal of Hematology
Subjects:
Online Access:https://journals.lww.com/10.4103/ijh.ijh_62_24
Tags: Add Tag
No Tags, Be the first to tag this record!